Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Atrial fibrillation.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 1 | Atrial fibrillation |
Biomarker and diagnostic research for atrial fibrillation, familial, 2 has been reported in the published literature.
No clinical trials have been registered for atrial fibrillation, familial, 2.
203 publications have been identified in PubMed for atrial fibrillation, familial, 2. Kisho has analyzed 156 by research type. Research spans Clinical Trial Publication (25%), Basic Science / Preclinical (24%), and Epidemiology / Natural History (22%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 39 | 25% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 6:24 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Laboratory research |
37 |
24% |
Disease patterns and progression | 34 | 22% |
Research summaries | 30 | 19% |
Testing and diagnosis research | 9 | 6% |
Patient case studies | 5 | 3% |
Other research | 1 | 1% |
New treatment approaches | 1 | 1% |
Kong LC (2026). [PMID: 41709802](https://pubmed.ncbi.nlm.nih.gov/41709802/). *JACC. Case reports*. [Case Report / Case Series]
Hardi H (2026). [PMID: 41524853](https://pubmed.ncbi.nlm.nih.gov/41524853/). *Cardiovasc Toxicol*. [Review / Meta-Analysis]
Genovese D (2026). [PMID: 41711708](https://pubmed.ncbi.nlm.nih.gov/41711708/). *ESC Heart Fail*. [Epidemiology / Natural History]
Brik T (2026). [PMID: 41620058](https://pubmed.ncbi.nlm.nih.gov/41620058/). *Heart Rhythm*. [Review / Meta-Analysis]
Stoll L (2026). [PMID: 40956862](https://pubmed.ncbi.nlm.nih.gov/40956862/). *Annual review of pharmacology and toxicology*. [Epidemiology / Natural History]
Rankinen J (2026). [PMID: 40664496](https://pubmed.ncbi.nlm.nih.gov/40664496/). *Heart*. [Epidemiology / Natural History]
Martínez-Barrios E (2026). [PMID: 41596527](https://pubmed.ncbi.nlm.nih.gov/41596527/). *International journal of molecular sciences*. [Epidemiology / Natural History]
Li JZ (2026). [PMID: 40221274](https://pubmed.ncbi.nlm.nih.gov/40221274/). *Cardiovascular revascularization medicine : including molecular interventions*. [Clinical Trial Publication]
Gong H (2026). [PMID: 41812233](https://pubmed.ncbi.nlm.nih.gov/41812233/). *Europace*. [Clinical Trial Publication]
Ding N (2026). [PMID: 41638192](https://pubmed.ncbi.nlm.nih.gov/41638192/). *Cell Metab*. [Basic Science / Preclinical]
AI-curated news mentioning atrial fibrillation, familial, 2
Updated Sep 9, 2026
An updated meta-analysis investigates the relationship between tirzepatide and the incidence of atrial fibrillation in adults with overweight or obesity. The findings contribute to understanding the cardiovascular safety profile of tirzepatide in this patient population.
A recent case series highlights life-threatening delayed myocardial ischemia and ventricular arrhythmias following pulmonary vein isolation (PFA) for atrial fibrillation (AF). This study underscores the potential risks associated with PFA procedures, emphasizing the need for careful patient monitoring.
New research demonstrates that multi-trait polygenic risk scores enhance the genomic prediction of atrial fibrillation across various ancestries. This advancement could lead to improved risk assessment and personalized treatment strategies for patients.